Invention Application
US20080207685A1 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
审中-公开
杂环化合物作为过氧化物酶体增殖物激活受体的调节剂，可用于治疗和/或预防由Ppar调节的疾病
- Patent Title: Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
- Patent Title (中): 杂环化合物作为过氧化物酶体增殖物激活受体的调节剂，可用于治疗和/或预防由Ppar调节的疾病
-
Application No.: US10577828Application Date: 2004-11-16
-
Publication No.: US20080207685A1Publication Date: 2008-08-28
- Inventor: James Robert Henry , Yihong Li , Jeffrey Michael Scheryantz , Alan M. Warshawsky
- Applicant: James Robert Henry , Yihong Li , Jeffrey Michael Scheryantz , Alan M. Warshawsky
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly And Company
- Current Assignee: Eli Lilly And Company
- Current Assignee Address: US IN Indianapolis
- International Application: PCT/US2004/035530 WO 20041116
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; C07D217/24 ; A61P3/10 ; A61P9/10 ; A61P3/04
Abstract:
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
Information query
IPC分类:
